+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity



Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity



Research in Microbiology 145(3): 167-168




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 043505266

Download citation: RISBibTeXText

PMID: 7809466

DOI: 10.1016/0923-2508(94)90012-4


Related references

Cell envelope constituents and the multifaceted nature of Mycobacterium avium pathogenicity and drug resistance. Research in Microbiology 145(3): 243-52; Discussion 252-61, 1994

Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China. International Journal of Antimicrobial Agents 45(5): 491-495, 2016

Use of the bactec system for drug susceptibility testing of mycobacterium tuberculosis mycobacterium kansasii and mycobacterium avium complex. Diagnostic Microbiology & Infectious Disease 3(1): 33-40, 1984

Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy. Research in Microbiology 145(3): 188-196, 1994

Molecular characterization and drug susceptibility profile of a Mycobacterium avium subspecies avium isolate from a dog with disseminated infection. Journal of Medical Microbiology 65(4): 278-285, 2016

Factors influencing the chlorine susceptibility of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. Applied and Environmental Microbiology 69(9): 5685-5689, 2003

Drug susceptibility testing of Mycobacterium Avium subsp. Avium isolates from naturally infected domestic pigeons to avian tuberculosis. International Journal of Mycobacteriology 5 Suppl 1: S217-S218, 2017

Oral infection of ferrets with virulent Mycobacterium bovis or Mycobacterium avium: susceptibility, pathogenesis and immune response. Journal of Comparative Pathology 123(1): 15-21, 2000

Contributing factors of pathogenesis in the Mycobacterium avium complex. Research in Microbiology 142(4): 427-433, 1991

Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare. Journal of Clinical Microbiology 52(12): 4439-4440, 2015

Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens. Journal of Infection and ChemoTherapy 24(4): 315-318, 2017

Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex. Clinical Microbiology and Infection 2018, 2018

Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. Journal of Infection and ChemoTherapy 12(4): 195-202, 2006

Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrobial Agents and ChemoTherapy 37(7): 1556-1557, 1993

In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid. Antimicrobial Agents and ChemoTherapy 31(1): 132-133, 1987